Sintx Technologies, Inc. (SINT)
NASDAQ · Instruments & Medical Devices · Surgical & Medical Instruments & Apparatus
- Price
- $1.78
- Day
- -2.73%
- Market cap
- $11.86M
Close 2026-09-23.
The company
Overview – SINTX Technologies SINTX Technologies is an advanced ceramics company formed in December 1996 that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX provides biomedical solutions for medical devices specializing in silicon nitride (Si₃N₄) for musculoskeletal and antipathogenic applications. We also manufacture parts made from silicon nitride for customers in the electrical, aerospace and other industrial sectors.
From Item 1: Overview.
By product & service
- Product — 72%
- Grant and Contract — 28%
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- Bleichroeder LP — $978.03K
- Stonepine Capital Management, LLC — $558.43K
- Stonepine Capital Management, LLC — $332.53K
- Veracity Capital LLC — $143.38K
- CITADEL ADVISORS LLC — $59.71K
- VANGUARD FIDUCIARY TRUST CO — $44K
- GEODE CAPITAL MANAGEMENT, LLC — $42.89K
- VANGUARD CAPITAL MANAGEMENT LLC — $39.09K
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Lyons Christopher Michael (Director) bought 7,534 shares at $2.90 on 2026-03-02
- Lyons Christopher Michael (Director) bought 758 shares at $2.96 on 2026-02-25
- MOYES JAY M (Director) bought 1,000 shares at $2.91 on 2026-02-23
- Anderson Mark Lewis (Director) bought 3,000 shares at $3.02 on 2026-02-18
- Honigblum Gregg R. (Chief Investment Officer) bought 5,000 shares at $4.24 on 2025-12-08
- Honigblum Gregg R. (Chief Investment Officer) bought 3,200 shares at $4.28 on 2025-12-08
Recent filings
- EFFECT — 2026-08-18
- 8-K — 2026-08-13
- SCHEDULE 13G — 2026-08-13
- S-3 — 2026-08-13
- 8-K — 2026-08-11
- 10-Q — 2026-08-11
- 8-K — 2026-07-23
- 8-K — 2026-07-02
- EFFECT — 2026-06-30
- S-3 — 2026-06-25